Sumnuay To provide an accurate evaluation of the association of human papillomavirus (HPV) with lung cancer. 36 cases of lung cancer were analysed for HPV DNAs by polymerase chain reaction (PCR) with dot-blot and Southern blot analyses, and for the transcripts from the E6-E7 transforming region by in situ hybridisation (ISH). HPV-18 DNA was detected in three (8%) of 36 specimens; histologically. in one (10%) of 10 squamous cell carcinomas and two (9%) of 22 adenocarcinomas. Neither HPV-16 nor -33 DNA was detected in any cases examined. Expression of E6-E7 mRNA was confirmed in the cases which contained HPV-18 DNA. HPV-18 may play an important role in the development and progression of cancer in some cases of both squamous cell carcinoma and adenocarcinoma of the lung.
Human papillomaviruses (HPVs) are a heterogeneous group of double-stranded, non-enveloped DNA viruses with over 60 genotypes (for review, see de Villiers, 1989) . They cause benign epithelial proliferations, but some types of HPV have been implicated in the pathogenesis of carcinomas for many sites, including the anogenital area, oropharynx and upper respiratory tract (Shindoh et al., 1992; Stoler et al., 1992; Anwar et al., 1993) . In particular, more than 90% of cervical carcinomas contain HPV DNAs that usually correspond to HPV-16 and HPV-18, so-called 'high-risk HPVs', and, less frequently, (for review, see zur Hauzen, 1991) .
High-risk HPV DNAs are frequently integrated into cellular DNA in these cancers. and the long-control region and the E6 and E7 regions of the HPV genome are preferentially conserved, although other regions of the genome are often deleted (Schwarz et al.. 1985; Takebe et al., 1987) . The E6 and E7 regions of high-risk HPVs can immortalise primary human cervical, epidermal, mammary and even bronchial epithelial cells (Woodworth et al., 1988; Hawley et al., 1989; Band et al.. 1990; Willey et al., 1991) . The E6 and E7 proteins of high-risk HPVs bind to the proteins encoded by the host tumour-suppressor genes. the p53 and retinoblastoma susceptibility (RB) genes respectively, to disrupt their normal function for controlling the cell cycle (Munger et al.. 1989; Scheffner et al., 1990; Werness et al., 1990) .
Recent studies revealed that the p53 gene is mutated in 73% of small-cell lung cancers (SCLCs) and 45% of nonsmall cell lung cancers (NSCLCs) (Chiba et al., 1990; Takahashi et al., 1991) and that the RB gene is inactivated in 60-100% of SCLC cell lines and 32% of primary NSCLCs (Harbour et al., 1988; Yokota et al., 1988; Reissmann et al., 1993) . Because alterations of the p53 and RB genes are involved in many lung cancers, pulmonary infection with high-risk HPV might play an important role in the development and progression of lung cancer through the inactivation of the p53 and RB genes.
In lung cancer, HPV Ostrow et al., 1987; Syrjanen et al., 1989; Bejui et al., 1990; Yousem et al., 1992) . To provide a more accurate evaluation of the association of HPV with lung cancer, we examined the existence of HPV DNA in lung cancer tissues by a polymerase chain reaction (PCR) method and dot-blot hybridisation, and confirmed it by analysing the PCR product with Southern blot hybridisation and the expression of E6-E7 mRNA with in situ hybridisation (ISH). Furthermore, the mechanisms involved in pulmonary carcinogenesis associated with HPV are discussed.
Materialis a nd mthods
Tissue specimens and DNA preparation Tissue from 36 lung cancers was obtained by surgical resection or autopsy from Hokkaido University Hospital, Sapporo Minami-Ichijo Hospital and National Sapporo Minami Hospital during 1988 and 1992. Samples were taken 1-3 h after death in autopsy cases. All samples were divided into two parts, one frozen in liquid nitrogen and stored at -80°C for DNA preparation and the other routinely fixed in formalin and embedded in paraffin for haematoxylin and eosin staining and ISH. According to the 1981 WHO classification, they were diagnosed histopathologically as adenocarcinoma (n = 22), squamous cell carcinoma (n = 10), small-cell carcinoma (n = 2), adenosquamous carcinoma (n = 1) and metastatic lung cancer of tongue carcinoma (n = 1). Genomic DNA was isolated by proteinase K digestion followed by phenol/chloroform extraction and ethanol precipitation (Maniatis et al., 1989) .
Primers and probes for potjymerase chain reaction (PCR) Type-specific primers and probes were synthesised on a DNA synthesiser (MilfiGen/Bioresearch, Brulington, USA) on the basis of published sequences of HPV-16, -18 and -33, as previously described (Shimada et al., 1990) . In brief, the primer p16-1 (5'-AAGGGCGTAACCGAAATCGGT-3') was located close to the 5' end of the E6 sense sequence of HPV-16, which was available as a common primer of . The primers p16-2R (5'-GTTTGCAGCTCT-GTGCATA-3'), pl8-2R (5'-GTGTTCAGTTCCGTGCACA-3') and p33-2R (5'-GTCTCCAATGCFTGGCACA-3'), corresponding to type-specific E6 antisense sequences of HPV-16, -18 and -33 respectively, were located in the middle of E6 open reading frame (ORF). The oligonucleotide probes pB16-I (5'-CAT`I-TATGCACCAAAAGAGAACT-GCAATG-3), pB18-I (5'-TGAGAAACACACCACAATAC-TATGGCGCGC-3') and pB33-I (5'-CATTlTGCAGTAAG-GTACTGCACGACTATG-3) were also type-specific for HPV-16, -18 and -33 respectively, and located in the middle of amplified regions.
PCR and dot-blot hybridisation PCR was performed essentially as described by Shimada et al. (1990) . Cloned c.p.m. ml-' for a ES-labelled probe. After hybridisation, slides were washed under high-stringency conditions (Tm-O1C). For digoxigenin-labelled probe, immunodetection was carried out by using a DIG ELISA Detection Kit (Boehringer Mannheim). In brief, sections were incubated with alkaline phosphatase conjugated antidigoxigenin antibody diluted 1:500 in 0.1 M Tris-HCI, pH 7.5, 0.15 M sodiurm chloride for 30 min. After washes, slides were immersed in a mixture of nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) solution overnight and counterstained with methyl green. For a 3S-labelled probe, slides were overlaid with Konika NRM-2 autoradiography emulsion (Konika, Tokyo, Japan), exposed for 3 weeks at 4'C, developed photographically and counterstained with haematoxylin and eosin.
For controls, a known HPV-18 E6-E7 mRNA-positive cell line (HeLa) and a known HPV-negative cell line (C-33A) (Schwarz et al., 1985; Yee et al., 1985) were grown on chamber sde gss (Nunc, Napervilk, USA), fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 mi, and then processed for ISH.
Res
We performed the PCR using HPV type-specific primers and dot-blot hybridisation assay using HPV type-specific probes to elucidate the role of HPV in the development and progression of lung cancer. HPV-18 DNA was detected in three (8%) of 36 specimens; histologically, in one (10%) of 10 squamous cell carcinomas and two (9%) of 22 adenocarcinomas (Table I) In the HPV-positive cases, we performed ISH using digoxigenin-labeled riboprobes corresponding to the E6-E7 region of HPV-18 to confirm that the result of PCR was not false positive and that the tumour cells in fact expressed mRNA of the E6-E7 transforming region.
An HPV-positive cell line (HeLa) and an HPV-negative cell line (C-33A) were used as controls. Strong cytoplasmic signals with the E6-E7 aniisense probe and no signals with the sense probe were observed in HeLa cells (Figure 3a and data not shown). No hybridised signals with either probe were detected in C-33A cells (Figure 3b and data not shown) .
The case of squamous cell carcinoma that was HPV-18-positive in PCR analysis (case 1 in Table H ) exhibited abun- confirmed by the control hybridisation experiment with the sense probe, which abolished the hybridised signals ( Figure  4b ). One case of adenocarcinoma with HPV-18 DNA in PCR analysis (case 2 in Table II) showed cytoplasmic hybridised signals with the antisense probe (Figure 5a ). These signals - were also abolished with the sense probe ( Figure 5b ). anaplastic carcinoma of the lung by in situ DNA hybridisation and Southern blot hybridisation Ostrow et al., 1987; Syrainen et al., 1989; Bejui et al., 1990; Yousem et al., 1992 (Higgins et al., 1991) .
It is noteworthy that we detected in two cases of adenocarcinoma, because HPV has been thought to infect squamous cell metaplasia but not native columnar epithelium, and thus not to be involved in the genesis of adenocarcinoma of the lung (Bejui et al., 1990) . However, in cervical cancer, high-risk HPV is known to be involved in the carcinogenesis of three major histological cell types: squamous, glandular and small-cell types (Stoler et al., 1992) . Whereas HPV-16 is the most prevalent virus infecting the uterine cervix and is closely associated with squamous cell carcinomas, and sometimes with adenocarcinomas, HPV-18 is most consistently associated with adenocarcinomas and small-cell neuroendocrine carcinomas of the cervix and less frequently with squamous cell carcinomas (Tase et al., 1988; Stoler et al., 1991) . Together with these findings, our findings suggest that HPV-18 can be involved in the pathogenesis of adenocarcinoma of the lung as well as that of the cervix.
Stoler et al. (1992) found that most HPV-16 DNAs existed in a mixed episomal and integrated state, whereas all HPV-18 DNAs existed in an integrated state, regardless of the cell type. Therefore, they suggested three possibilities with regard to the virus-host relationship, none of which were mutually exclusive: first, the virus infected a multipotent precursor cell; second, the virus preferentially infected a cell already committed to a certain cell type; and, third, the virus exerted some influence on cell differentiation. Their suggestions and our present findings that all three HPV-positive patients were smokers indicated that HPV might infect multipotent basal cells in the bronchial epithelium at sites of microabrasion caused by smoking, or at the border of the metaplastic mucosa, equivalent to the transitional zone of the uterine cervix. Through these possible mechanisms, high-risk HPVs, especially , are thought to be involved in the development and progression of both squamous cell carcinoma and adenocarcinoma of the lung.
We only detected HPV-18, although previous studies reported that was more prevalent than HPV-18 in lung cancer in Western countries  Ostrow et Syrjinen et al., 1989) . This difference might be caused by geographic or racial factors, as was shown in laryngeal cancer (Anwar et al., 1993) .
In a recent study it was shown that bronchial papillomas associated with HPV-16 and/or -18 are at high risk for the development of squamous cell carcinoma (Popper et al., 1992) . However, we could not find a papillomatous lesion in the neighbouring area of the HPV-positive squamous cell carcinoma. We suggest that not all squamous cell carcinomas associated with HPV-18 arise from the benign papillomatous lesion, which is consistent with the observation reported by Syrjinen et al., (1989) (Munger et al., 1989; Scheffner et al., 1990; Werness et al., 1990) . It also has been reported that high-risk HPVs cooperate with an activated ras oncoprotein to transform baby rat kidney cells (Storey et al., 1988) , and that E7 protein of high-risk HPV overcomes the inhibition of c-mvc expression by transforming growth factor , (Pietenpol et al., 1990) . We examined the three HPV-positive lung cancers for the mutation of p53 by the PCR-based single-strand conformation polymorphism (SSCP) analysis of exon 5 to exon 9 and found p53 mutation in all three cases (in preparation). This finding suggests that the cellular target for HPV is not p53 in these cases and that there may be other cellular targets for HPV. The molecular mechanisms involved in the development and progression of lung cancer by HPV remain to be determined.
